Cancer has complex pathophysiology and is one of the primary causes of death and
morbidity across the world. Chemotherapy, targeted therapy, radiation therapy, and …

Personalized cancer vaccines (PCVs) are reinvigorating vaccine strategies in cancer
immunotherapy. In contrast to adoptive T-cell therapy and checkpoint blockade, the PCV …

Cancer immunotherapy is quickly growing to be the fourth most important cancer therapy,
after surgery, radiation therapy, and chemotherapy. Immunotherapy is the most promising …

Dendritic cells (DCs) are the primary antigen-presenting cells and play key roles in the
orchestration of the innate and adaptive immune system. Targeting DCs by nanotechnology …

Therapeutic cancer vaccines require robust cellular immunity for the efficient killing of tumor
cells, and recent advances in neoantigen discovery may provide safe and promising targets …

Mesoporous silica nanoparticles (MSNPs) are a particular example of innovative
nanomaterials for the development of drug delivery systems. MSNPs have recently received …

Phagocytes, particularly dendritic cells (DCs), generate peptide-major histocompatibility
complex (MHC) I complexes from antigens they have collected from cells in tissues and …

Vaccines harness the inherent properties of the immune system to prevent diseases or treat
existing ones. Continuous efforts have been devoted to both gaining a mechanistic …

Vaccination is the most valuable and cost-effective health measure to prevent and control
the spread of infectious diseases. A significant number of infectious diseases and chronic …

The versatility and nanoscale size have helped nanoparticles (NPs) improve the efficacy of
conventional cancer immunotherapy and opened up exciting approaches to combat cancer …